Cargando…

Clinical profile of patients with seronegative celiac disease

AIM: This study aimed to determine the clinical profile of patients with seronegative celiac disease (SNCD). BACKGROUND: Celiac disease (CD) is mainly diagnosed based on positive serology and duodenal mucosal atrophy, but some patients have negative serology. Their diagnosis has some limitations; de...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahmanipour, Elham, Ghorbani, Mohammad, Ganji, Azita, Mirzaei, Zahra, Ghavami, Vahid, Shahbazkhani, Bijan, Attarian, Fahime, Amiri, Masoumeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404820/
https://www.ncbi.nlm.nih.gov/pubmed/37554750
http://dx.doi.org/10.22037/ghfbb.v16i2.2756
_version_ 1785085384983576576
author Rahmanipour, Elham
Ghorbani, Mohammad
Ganji, Azita
Mirzaei, Zahra
Ghavami, Vahid
Shahbazkhani, Bijan
Attarian, Fahime
Amiri, Masoumeh
author_facet Rahmanipour, Elham
Ghorbani, Mohammad
Ganji, Azita
Mirzaei, Zahra
Ghavami, Vahid
Shahbazkhani, Bijan
Attarian, Fahime
Amiri, Masoumeh
author_sort Rahmanipour, Elham
collection PubMed
description AIM: This study aimed to determine the clinical profile of patients with seronegative celiac disease (SNCD). BACKGROUND: Celiac disease (CD) is mainly diagnosed based on positive serology and duodenal mucosal atrophy, but some patients have negative serology. Their diagnosis has some limitations; delays in diagnosis are likely accompanied by a poor prognosis and a high risk of developing complications of CD. METHODS: In this retrospective study, 1115 patients were evaluated for CD with mucosal atrophy between 2010 to 2020. SNCD diagnosis requires genetic CD predisposition and improvement of both clinical symptoms and regrowth of duodenal villi after 12 months of a gluten-free diet (GFD) for all patients with IgA deficiency, other IgG-based serology for diagnosis of celiac was done and if these antibodies were negative, consider them as possible SNCD. If they had positive DQ2-DQ8 and improvement of clinical symptoms and mucosal atrophy after 12 months of GFD were confirmed SNCD. RESULTS: Of the 1115 study subjects, 27 had SNCD, 1088 had SPCD with a mean age of 29.7±15.7 years (1 to 76 years) in seropositive celiac disease (SPCD) subjects and 37.1±16.3 years (6 to 63 years) in SNCD participants and 19 female patients with SNCD were presented. The BMI of SNCD and SPCD patients were reported 23.9 and 21.4, respectively. In addition, SPCD subjects were more likely but not statistically significant to have a positive family history. Villous atrophy was shown in 100% SNCD and 95.6% SPCD cases. Scalloping and fissuring in duodenal biopsies were reported in 60% of SNCD and 84.5% of SPCD patients. There was some other cause of seronegative villous atrophy including 3 patients with Crohns disease, 2 with common variable immunodeficiency, 2 drug and one patient with peptic duodenitis. Anemia, neurological symptoms, and liver function tests (LFT) abnormality were common extra intestinal manifestations in SNCD individuals. Levels of Thyroid peroxidase (TPO), TSH were measured, it had been detected that SNCD cases had a higher rate of co-occurrence with thyroid diseases also SPCD cases showed a higher rate of co-occurrence with diabetes. CONCLUSION: Among patients with celiac disease 2.4% are SNCD. SNCD are older than SPCD at the time of diagnosis and have higher BMI. Most common of cause of seronegative enteropathy also is SNCD followed by inflammatory bowel disease (IBD) common variable immunodeficiency (CVID), medication use, and duodenitis, in this area.
format Online
Article
Text
id pubmed-10404820
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Shaheed Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-104048202023-08-08 Clinical profile of patients with seronegative celiac disease Rahmanipour, Elham Ghorbani, Mohammad Ganji, Azita Mirzaei, Zahra Ghavami, Vahid Shahbazkhani, Bijan Attarian, Fahime Amiri, Masoumeh Gastroenterol Hepatol Bed Bench Original Article AIM: This study aimed to determine the clinical profile of patients with seronegative celiac disease (SNCD). BACKGROUND: Celiac disease (CD) is mainly diagnosed based on positive serology and duodenal mucosal atrophy, but some patients have negative serology. Their diagnosis has some limitations; delays in diagnosis are likely accompanied by a poor prognosis and a high risk of developing complications of CD. METHODS: In this retrospective study, 1115 patients were evaluated for CD with mucosal atrophy between 2010 to 2020. SNCD diagnosis requires genetic CD predisposition and improvement of both clinical symptoms and regrowth of duodenal villi after 12 months of a gluten-free diet (GFD) for all patients with IgA deficiency, other IgG-based serology for diagnosis of celiac was done and if these antibodies were negative, consider them as possible SNCD. If they had positive DQ2-DQ8 and improvement of clinical symptoms and mucosal atrophy after 12 months of GFD were confirmed SNCD. RESULTS: Of the 1115 study subjects, 27 had SNCD, 1088 had SPCD with a mean age of 29.7±15.7 years (1 to 76 years) in seropositive celiac disease (SPCD) subjects and 37.1±16.3 years (6 to 63 years) in SNCD participants and 19 female patients with SNCD were presented. The BMI of SNCD and SPCD patients were reported 23.9 and 21.4, respectively. In addition, SPCD subjects were more likely but not statistically significant to have a positive family history. Villous atrophy was shown in 100% SNCD and 95.6% SPCD cases. Scalloping and fissuring in duodenal biopsies were reported in 60% of SNCD and 84.5% of SPCD patients. There was some other cause of seronegative villous atrophy including 3 patients with Crohns disease, 2 with common variable immunodeficiency, 2 drug and one patient with peptic duodenitis. Anemia, neurological symptoms, and liver function tests (LFT) abnormality were common extra intestinal manifestations in SNCD individuals. Levels of Thyroid peroxidase (TPO), TSH were measured, it had been detected that SNCD cases had a higher rate of co-occurrence with thyroid diseases also SPCD cases showed a higher rate of co-occurrence with diabetes. CONCLUSION: Among patients with celiac disease 2.4% are SNCD. SNCD are older than SPCD at the time of diagnosis and have higher BMI. Most common of cause of seronegative enteropathy also is SNCD followed by inflammatory bowel disease (IBD) common variable immunodeficiency (CVID), medication use, and duodenitis, in this area. Shaheed Beheshti University of Medical Sciences 2023 /pmc/articles/PMC10404820/ /pubmed/37554750 http://dx.doi.org/10.22037/ghfbb.v16i2.2756 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/) which permits others to copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Original Article
Rahmanipour, Elham
Ghorbani, Mohammad
Ganji, Azita
Mirzaei, Zahra
Ghavami, Vahid
Shahbazkhani, Bijan
Attarian, Fahime
Amiri, Masoumeh
Clinical profile of patients with seronegative celiac disease
title Clinical profile of patients with seronegative celiac disease
title_full Clinical profile of patients with seronegative celiac disease
title_fullStr Clinical profile of patients with seronegative celiac disease
title_full_unstemmed Clinical profile of patients with seronegative celiac disease
title_short Clinical profile of patients with seronegative celiac disease
title_sort clinical profile of patients with seronegative celiac disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404820/
https://www.ncbi.nlm.nih.gov/pubmed/37554750
http://dx.doi.org/10.22037/ghfbb.v16i2.2756
work_keys_str_mv AT rahmanipourelham clinicalprofileofpatientswithseronegativeceliacdisease
AT ghorbanimohammad clinicalprofileofpatientswithseronegativeceliacdisease
AT ganjiazita clinicalprofileofpatientswithseronegativeceliacdisease
AT mirzaeizahra clinicalprofileofpatientswithseronegativeceliacdisease
AT ghavamivahid clinicalprofileofpatientswithseronegativeceliacdisease
AT shahbazkhanibijan clinicalprofileofpatientswithseronegativeceliacdisease
AT attarianfahime clinicalprofileofpatientswithseronegativeceliacdisease
AT amirimasoumeh clinicalprofileofpatientswithseronegativeceliacdisease